Terns Pharmaceuticals, Inc. (TERN) has a market capitalization of $4.75B and trades at $52.68. The 52-week range is 1.865-53.19.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -51.1, Earnings Per Share (EPS) of $-1.03.
The stock has a beta of -0.38, operates in the Healthcare sector.
